Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
NCT06795581Phase 1Recruiting
- Sponsor
- National Institute of Mental Health
- Start
- Mar 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]PF-06445974 in alcohol use disorder (AUD), sponsored by National Institute of Mental Health. Primary endpoint: Distribution Volume at 36 months. Started Mar 2025; status: recruiting.
02
Drugs
[18F]PF-06445974
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06795581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06795581.